Skip to main content

Table 1 Clinical, radiological, and PET/CT characteristics of the enrolled patients

From: Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma

Characteristics

All patients

PAS

PTE

P value

Age (median, range, years)

59 (15–88)

50 (27–69)

62 (15–88)

0.053

 < 59, n

23

11

12

0.011*

 ≥ 59, n

24

3

21

 

Gender, n

    

 Male

29

9

20

0.812

 Female

18

5

13

 

Symptom, n

    

 Dyspnea

    

  Yes

19

8

11

0.128

  No

28

6

22

 

 Chest tightness

    

  Yes

12

4

8

0.731

  No

35

10

25

 

 Chest pain

    

  Yes

12

6

6

0.076

  No

35

8

27

 

 Cough

    

  Yes

20

7

13

0.501

  No

27

7

20

 

 Hemoptysis

    

  Yes

5

2

3

0.627

  No

42

12

30

 

 Fever

    

  Yes

6

2

4

1.000

  No

41

12

29

 

D-dimer level, n

    

 Abnormal

39

9

30

0.087

 Normal

7

4

3

 

Location, n

    

 With PT involved

14

11

3

< 0.001*

  PT only

2

1

1

 

  PT and RPA

3

3

0

 

  PT and LPA

1

1

0

 

  PT, RPA, and LPA

8

6

2

 

 Without PT involved

33

3

30

 

  RPA

16

2

14

 

  LPA

6

1

5

 

  RPA and LPA

11

0

11

 

Non-enhanced CT value (HU)

36 (18–63)

34 (18–47)

39 (24–63)

0.062

 < 36, n

21

8

13

0.263

 ≥ 36, n

26

6

20

 

Enhanced CT value (HU)

49 (26–76)

67 (31–76)

45 (26–64)

< 0.001*

 < 49, n

23

3

20

0.024*

 ≥ 49, n

24

11

13

 

ΔCT value (HU)

5 (0–44)

25 (13–44)

4 (0–18)

< 0.001*

 < 20, n

36

3

33

< 0.001*

 ≥ 20, n

11

11

0

 

SUVmax

2.0 (0.8–17.2)

8.9 (3.0–17.2)

1.8 (0.8–3.7)

< 0.001*

 < 2.0, n

21

0

21

< 0.001*

 ≥ 2.0, n

36

14

12

 
  1. PAS pulmonary artery sarcoma, PTE pulmonary thromboembolism, PT pulmonary trunk, RPA right pulmonary artery, LPA left pulmonary artery
  2. *Indicated statistically significant